Susquehanna International Group, LLP Cyma Bay Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.63 - $24.47 $1.11 Million - $2.14 Million	-87,596 Reduced 56.13%	68,457 $1.62 Million
Q3 2023 Nov 14, 2023	BUY	$10.86 - $17.62 $402,764 - $653,472	37,087 Added 31.17%	156,053 $2.33 Million
Q2 2023 Aug 11, 2023	SELL	$7.47 - $10.95 $7.96 Million - $11.7 Million	-1,065,457 Reduced 89.96%	118,966 $1.3 Million
Q1 2023 May 16, 2023	BUY	$5.88 - $9.59 $4.6 Million - $7.51 Million	782,755 Added 194.88%	1,184,423 $10.3 Million
Q4 2022 Feb 14, 2023	BUY	$3.22 - $6.27 $935,036 - $1.82 Million	290,384 Added 260.94%	401,668 $2.52 Million

Q3 2022 Nov 14, 2022	BUY	$2.77 - $4.25 $308,256 - $472,957	111,284 New	111,284 $389,000
Q1 2022 May 16, 2022	BUY	$2.77 - $3.64 $70,837 - $93,085	25,573 Added 235.8%	36,418 $113,000
Q4 2021 Feb 14, 2022	SELL	$3.23 - $4.6 $211,849 - $301,704	-65,588 Reduced 85.81%	10,845 $37,000
Q2 2021 Aug 11, 2021	SELL	$3.94 - $4.92 $138,672 - $173,164	-35,196 Reduced 31.53%	76,433 $333,000
Q1 2021 May 17, 2021	BUY	$4.23 - $6.55 $141,730 - $219,464	33,506 Added 42.89%	111,629 $507,000
Q4 2020 Feb 16, 2021	SELL	$5.73 - $9.03 $1.13 Million - $1.79 Million	-197,754 Reduced 71.68%	78,123 $448,000
Q2 2020 Aug 14, 2020	BUY	$1.41 - $4.25 $263,898 - $795,438	187,162 Added 210.97%	275,877 $963,000
Q1 2020 May 15, 2020	BUY	$1.25 - $2.02 $3,525 - $5,696	2,820 Added 3.28%	88,715 $131,000
Q4 2019 Feb 14, 2020	BUY	$1.33 - $5.93 $12,259 - $54,662	9,218 Added 12.02%	85,895 $168,000
Q3 2019 Nov 14, 2019	BUY	$5.12 - $7.21 $245,939 - $346,332	48,035 Added 167.71%	76,677 $393,000
Q2 2019 Aug 16, 2019	SELL	$6.05 - $13.66 $336,531 - $759,837	-55,625 Reduced 66.01%	28,642 $205,000
Q1 2018 May 15, 2018	BUY	$9.0 - $15.16 $282,303 - $475,523	31,367 Added 59.29%	84,267 $1.1 Million
Q4 2017 Feb 14, 2018	BUY	$7.67 - $9.31 $188,758 - $229,119	24,610 Added 86.99%	52,900 $487,000
Q3 2017 Nov 14, 2017	BUY	$5.95 - $8.26 $168,325 - $233,675	28,290	28,290 $228,000

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.88M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account